StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)

Close on Nov 17, 2026Market cap $26.73BP/E –Yield –

Insmed total assets

Total assets on the balance sheet at the end of each period.

Insmed's total assets was $2.23B at Sep 30, 2026. For fiscal 2025 it was $2.26B, up 11.8% from the year before. Over ten years it grew 20.3% a year on average. The highest annual figure on record is $2.26B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.26B+11.8%
FY2024Dec 31, 2024$2.03B+52.3%
FY2023Dec 31, 2023$1.33B-19.7%
FY2022Dec 31, 2022$1.66B+33.2%
FY2021Dec 31, 2021$1.24B+56.2%
FY2020Dec 31, 2020$796.16M+7.3%
FY2019Dec 31, 2019$742.30M+22.8%
FY2018Dec 31, 2018$604.56M+30.8%
FY2017Dec 31, 2017$462.05M+94.2%
FY2016Dec 31, 2016$237.96M-33.3%
FY2015Dec 31, 2015$356.56M+54.4%
FY2014Dec 31, 2014$230.86M+30.8%
FY2013Dec 31, 2013$176.50M+14.9%
FY2012Dec 31, 2012$153.56M+9.8%
FY2011Dec 31, 2011$139.83M-28.8%
FY2010Dec 31, 2010$196.27M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.23B-5.7%
Q2 FY2026Jun 30, 2026$2.10B-15.2%
Q1 FY2026Mar 31, 2026$2.08B+15.2%
Q4 FY2025Dec 31, 2025$2.26B+11.8%
Q3 FY2025Sep 30, 2025$2.36B+15.0%
Q2 FY2025Jun 30, 2025$2.48B+37.0%
Q1 FY2025Mar 31, 2025$1.80B+55.5%
Q4 FY2024Dec 31, 2024$2.03B+52.3%
Q3 FY2024Sep 30, 2024$2.05B+55.0%
Q2 FY2024Jun 30, 2024$1.81B+25.8%
Q1 FY2024Mar 31, 2024$1.16B-23.6%
Q4 FY2023Dec 31, 2023$1.33B-19.7%
Q3 FY2023Sep 30, 2023$1.32B+33.2%
Q2 FY2023Jun 30, 2023$1.44B+36.6%
Q1 FY2023Mar 31, 2023$1.52B+31.6%
Q4 FY2022Dec 31, 2022$1.66B+33.2%
Q3 FY2022Sep 30, 2022$994.82M-24.2%
Q2 FY2022Jun 30, 2022$1.05B-14.3%
Q1 FY2022Mar 31, 2022$1.15B+66.6%
Q4 FY2021Dec 31, 2021$1.24B+56.2%
Q3 FY2021Sep 30, 2021$1.31B+56.0%
Q2 FY2021Jun 30, 2021$1.23B+38.9%
Q1 FY2021Mar 31, 2021$692.39M+2.3%
Q4 FY2020Dec 31, 2020$796.16M+7.3%
Q3 FY2020Sep 30, 2020$840.72M+10.2%
Q2 FY2020Jun 30, 2020$885.37M+10.3%
Q1 FY2020Mar 31, 2020$676.53M+13.5%
Q4 FY2019Dec 31, 2019$742.30M+22.8%
Q3 FY2019Sep 30, 2019$763.12M+15.4%
Q2 FY2019Jun 30, 2019$802.78M+10.8%
Q1 FY2019Mar 31, 2019$595.92M-22.9%
Q4 FY2018Dec 31, 2018$604.56M+30.8%
Q3 FY2018Sep 30, 2018$661.51M+30.7%
Q2 FY2018Jun 30, 2018$724.24M+337.2%
Q1 FY2018Mar 31, 2018$773.15M+285.3%
Q4 FY2017Dec 31, 2017$462.05M+94.2%
Q3 FY2017Sep 30, 2017$506.21M–
Q2 FY2017Jun 30, 2017$165.64M–
Q1 FY2017Mar 31, 2017$200.66M–
Q4 FY2016Dec 31, 2016$237.96M–

More Insmed figures

See a number that looks wrong?